89BIO, INC. - Annual Financials - Equity (SEC)

Updated on January 3, 2026.

Related Topics: SEC Topic List.

Data Source: SEC.

See details in table below.

You can see similar for other companies.

89BIO, INC. - Annual Equity (In Thousands of USD, Except Per Share Amounts)

Breakdown	2024-12-31	2023-12-31	2022-12-31
Beginning balance	-824511	536306	467374
Beginning balance, shares	119849.436	93269.377	50560.59
Issuance of common stock and warrants	136269	37	88219
Issuance of common stock and warrants, shares	13661.764	37029.105	18675.466
Issuance of common stock	2	37087	28449
Issuance of common stock, shares	1396.888	2168.539	3948.611
Issuance of common stock warrants related to amended term loan facility	608	482
Issuance of common stock upon exercise of common stock warrants	54207	15587	4
Issuance of common stock upon exercise of common stock warrants, shares	10179.789	2927.57	4202.499
Issuance of common stock upon cashless exercise of pre-funded warrants	-1		0
Issuance of common stock upon cashless exercise of pre-funded warrants, shares	799.906		3143.682
Issuance of common stock upon exercise of stock options	242	730	305
Issuance of common stock upon exercise of stock options, shares	76.003	247.162	151.061
Issuance of common stock upon vesting of restricted stock units, net of tax withholding for net share settlement	-2190	-2732	-298
Issuance of common stock upon vesting of restricted stock units, net of tax withholding for net share settlement, shares	412.558	309.194	103.703
Issuance of common stock under employee stock purchase plan	356	268	50
Issuance of common stock under employee stock purchase plan, shares	53.151	27.217	18.364
Stock-based compensation	20634	16106	10356
Net loss	-367079	-142189	-102026
Other comprehensive income (loss)	373	540	-286
Ending balance	-824511	536306	467374
Ending balance, shares	119849.436	93269.377	50560.59